Scrip Regulatory Affairs
US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
25 January 2012
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA issues much-awaited draft guidelines on developing biosimilars
- US FDA's de novo proposal will not result in significant time saving, says medtech association
- US PDUFA V deal adds 60-day cushion for new drug, biologic reviews
- US FDA draft proposals for companion diagnostics signals simultaneous drug/IVD review
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
